Kiran Mazumdar-Shaw Shaw spoke to Barkha Dutt, editor of Mojo, addressing doubts around India's COVID-19 vaccines rollout, on whether India's two approved vaccines are safe, what the difference is in the approval to the Serum Institute and Bharat Biotech vaccines and who should get the vaccines first. Here's Part 2 of the interview. Barkha: Are … Continue reading Decoding India’s Covid Vaccine Approvals with Kiran Mazumdar-Shaw: Part II
Decoding India’s two approved vaccines and looking at the rollout with Kiran Mazumdar Shaw
Kiran Mazumdar-Shaw Shaw spoke to Barkha Dutt, editor of Mojo, addressing doubts around India's COVID-19 vaccines rollout, on whether India's two approved vaccines are safe, what the difference is in the approval to the Serum Institute and Bharat Biotech vaccines and who should get the vaccines first. Here's Part 1 of the interview. Barkha Dutt: … Continue reading Decoding India’s two approved vaccines and looking at the rollout with Kiran Mazumdar Shaw
Indian regulator has granted Emergency Approval to Covaxin, Covishield based on strong scientific judgment.
India’s health regulator Drugs Controller General of India (DCGI) has granted Emergency Use Authorization (EUA) to two vaccines, Covaxin andCovishield , to fight the COVID-19 pandemic. Covaxin has been developed by Bharat Biotech in collaboration with the Indian Council for Medical Research (ICMR) and National Institute of Virology (NIV). Covishield has been developed by Oxford … Continue reading Indian regulator has granted Emergency Approval to Covaxin, Covishield based on strong scientific judgment.
India needs to inoculate a million people a day against COVID-19
India's health regulator Drugs Controller General of India (DCGI) has granted permission to two vaccines, Covishield and Covaxin, for "restricted use" in an emergency situation to fight the COVID-19 pandemic. Covishield has been developed by Oxford University scientists in collaboration with pharmaceutical company AstraZeneca. In India, its trial was undertaken by the Serum Institute of … Continue reading India needs to inoculate a million people a day against COVID-19
2021: A New Year of Hope!
By Kiran Mazumdar Shaw, Executive Chairperson, Biocon As 2020 draws to a close amid news of a second wave of COVID-19 cases and the emergence of a mutant strain of the novel coronavirus in many parts of the world, there is hope yet that 2021 will be a better year for humanity. Some silver linings … Continue reading 2021: A New Year of Hope!
World needs to balance risks, benefits and challenges of deploying COVID-19 vaccines
Biocon Executive Chairperson Kiran Mazumdar-Shaw recently spoke at Carnegie India’s Global Technology Summit, which convened leading policymakers, entrepreneurs, industry leaders, academics and technologists from around the world to deliberate over five days on an overarching theme of ‘Geopolitics of Technology’. On Dec. 18, 2020, the last day of the summit, Ms Mazumdar-Shaw joined Soumya Swaminathan, … Continue reading World needs to balance risks, benefits and challenges of deploying COVID-19 vaccines
Fostering MedTech Innovation in India
India's first corporate hospital-based technology business incubator for MedTech entrepreneurs - the Mazumdar Shaw Medical Foundation (MSMF) MedTech Innovation Center - was inaugurated at Narayana Health City Bangalore, in collaboration with BIRAC, Bionest program, on Dec 15, 2020. Launching the facility, Ms. Kiran Mazumdar-Shaw, founder of MSMF and Executive Chairperson, Biocon said the centre will … Continue reading Fostering MedTech Innovation in India
Kiran Mazumdar-Shaw recognized as the First Lady of Biotech by Asian Scientist Magazine
The Asian Scientist 100 is an annual listing of Asia's leading Scientists by the prestigious Asian Scientist Magazine. 2020 marks the 5th year of the launch of this list since 2016. Every year since 2016, Asian Scientist Magazine compiles a list of Asia’s most outstanding researchers. In the 2020 report, Asian Scientist Magazine has examined … Continue reading Kiran Mazumdar-Shaw recognized as the First Lady of Biotech by Asian Scientist Magazine
We must step up philanthropy for mental health: Kiran Mazumdar-Shaw
The COVID-19 pandemic has brought in its wake a tsunami of mental health concerns. A bad situation has been made worse by the limited healthcare resources available for people with mental illnesses as the entire focus is on containing the coronavirus situation. Children and older people, frontline health workers, people with existing mental health issues … Continue reading We must step up philanthropy for mental health: Kiran Mazumdar-Shaw
India Has Potential to Increase Covid Testing 10-Fold, Kiran Mazumdar-Shaw Says
India has the ability to aggressively ramp up coronavirus testing capacity, a move that will help it check a wave of new active cases hitting hospitals and skirt an economically unviable lockdown, according to Ms. Kiran Mazumdar-Shaw, the founder and chairman of Biocon Ltd. With pooled testing that can include as many as 10 people in one … Continue reading India Has Potential to Increase Covid Testing 10-Fold, Kiran Mazumdar-Shaw Says
